Quality over quantity

MSKCC team finds a neoantigen formula for pancreatic cancer

A study in Nature has challenged the assumption that pancreatic cancers are poorly immunogenic by linking long-term survival in patients to the quality, not the quantity, of neoantigens in expressed their tumors, highlighting the antigens’ potential as both markers and therapeutic targets for the disease.

“People have hypothesized that neoantigens are probably not

Read the full 523 word article

User Sign In